Literature DB >> 27530747

Transmissible colistin resistance encoded by mcr-1 detected in clinical Enterobacteriaceae isolates in Singapore.

Jeanette Wp Teo1, Ka Lip Chew1, Raymond Tp Lin1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27530747      PMCID: PMC5034101          DOI: 10.1038/emi.2016.85

Source DB:  PubMed          Journal:  Emerg Microbes Infect        ISSN: 2222-1751            Impact factor:   7.163


× No keyword cloud information.
Dear Editor, Following the recent description of transmissible plasmid-mediated colistin resistance encoded by mcr-1 in clinical and veterinary Escherichia coli and Klebsiella pneumoniae isolates in China,[1] several groups have reported mcr-1 in colistin-resistant isolates from humans and food animals across Asia[2, 3, 4] to Europe.[5, 6, 7, 8] It is evident that mcr-1 has disseminated globally. We performed a prospective study in January 2016 using 306 consecutive clinical Enterobacteriaceae isolates collected from blood, urine and miscellaneous samples (swabs and pus). The species investigated were E. coli (n=166), K. pneumoniae (n=87), Klebsiella oxytoca (n=4), Enterobacter spp. (n=22), Proteus spp. (n=10), Citrobacter spp. (n=9), Morganella morganii (n=5), Providencia rettgeri (n=1), Salmonella enteritidis (n=1) and Serratia marcescens (n=1). Isolates were PCR-screened for mcr-1[1] without prior knowledge of their antibiograms or colistin-resistance status. Three of these isolates (two E. coli and one K. pneumoniae) were mcr-1 positive, with their full-length mcr-1 gene matching the nucleotide identity of the first-described isolate exactly.[1] Multilocus sequence typing (MLST) was performed (http://bigsdb.web.pasteur.fr/index.html). There was no evidence of nosocomial transmission, as the two E. coli isolates were of different sequence types (STs; Table 1).
Table 1

Characteristics of mcr-1-positive clinical Enterobacteriaceae isolates in Singapore

IsolateSpecimenSpeciesDate of isolationMLSTβ-lactamasesISApl1 associatedmcr-1 transmissible via conjugationaMIC (mg/L)b
        PBCOLIMPMEMETPFOXCAZAMPPTZCIPLEVGEMAMK
NM12UrineE. coli11/01/2016ST460CTEM-1YesYes, ≈10−644≤0.25≤0.25≤0.5≤4≤1≥326424<1<2
NM4UrineE. coli14/01/2016ST156TEM-1NoYes, ≈10−744≤0.25≤0.25≤0.5≥6416≥32≤412>16<2
NM2UrineK. pneumoniae13/01/2016ST1535TEM-1, CTX-M-15NoYes, ≈10−3248≤0.25≤0.25≤0.5≤416≥32≤412<1<2
Transconjugant NM12E. coliTEM-122≤0.25≤0.25≤0.5≤4≤1≥3212824≤1≤2
Transconjugant NM4E. coliTEM-146≤0.25≤0.25≤0.5≤6416≥32≤412≥16≤2
Transconjugant NM2E. coliNot detected86≤0.25≤0.25≤0.5≤4≤18≤4≤0.25≤0.12≤1≤2
J53E. coli0.50.25≤0.25≤0.25≤0.5≤4≤18≤4≤0.25≤0.12≤1≤2

Abbreviations: amikacin, AMK; ampicillin, AMP; ceftazidime, CAZ; ciprofloxacin, CIP; colistin, COL; cefotaximase, CTX; ertapenem, ETP; cefoxitin, FOX; gentamicin, GEM; imipenem, IMP; levofloxacin, LEV; minimum inhibitory concentration, MIC; meropenem, MEM; polymyxin B, PB; piperacillin-tazobactam, PTZ.

The conjugation efficiency is calculated as the number of transconjugants per donor cell.

The interpretation of results of susceptibility testing were based on European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines. For colistin, a susceptible breakpoint of ≤2 mg/L and a resistant breakpoint of>2 mg/L was applied. Because no interpretative criteria are available for polymyxin B, colistin breakpoints were applied.

The Institut Pasteur MLST scheme was utilized. The following new allelic profile was obtained: dinB 22; pabB 21; putB 23; trpB 127; icdA 61; polB 109; trpA 41; uidA 164, and was assigned as ST460.

The isolates were urinary specimens (Table 1). Our detection rate was estimated to be 0.98% (95% confidence interval of 0.3%–2.8%, Wilson score interval). This was very close to 1% mcr-1 prevalence in China.[1] Sensitivity testing was performed via E-test for polymyxin B and colistin and with the Vitek2 GNR257 card for all other antimicrobials. Phenotypically, the isolates were resistant to polymyxin B (minimum inhibitory concentration (MIC) 4 mg/L–24 mg/L) and colistin (MIC 4 mg/L–8 mg/L) but were sensitive to carbapenems. There was a variable sensitivity to third-generation cephalosporins and piperacillin-tazobactam (Table 1). PCR screening for carbapenemases (K. pneumoniae carbapenemase (KPC), metallo-β-lactamases (New Delhi Metallo-β-lactamase (NDM), verona integron-encoded metallo-β-lactamase, imipenemase), class D carbapenemases (oxacillinase (OXA)-23, OXA-48-like)) and broad- and extended-spectrum β-lactamases (BSBL and ESBLs) was performed.[9] Only narrow-spectrum β-lactamase (TEM)-1 BSBL was detected in the E. coli isolates (Table 1). This was noteworthy because mcr-1-positive isolates have been found to be associated with cefotaximase (CTX)-M-like ESBLs.[4, 5, 6] Furthermore, in our isolates, carbapenemase genes were not carried with mcr-1, which contrasts growing reports in which mcr-1 has been found together with blaKPC-2 and blaNDM carbapenemase genes[7, 8] and results in colistin-resistant isolates that are also carbapenem resistant.[7, 8] Using liquid-mating assays, mcr-1 was transferable to an E. coli recipient, J53, in all the clinical donor isolates. Transconjugants were selected on Luria Bertani agar containing 50 mg/L of sodium azide and 0.5 mg/L of colistin. All of the transconjugants were phenotypically resistant to colistin and polymyxin B. TEM-1 also transferred in two transconjugants (Table 1). PCR replicon typing[10] indicated that the transconjugants of NM2 and NM12 could not be typed, while transconjugant NM4 carried IncF and IncI1. The genetic environment of mcr-1 is variable and is not always associated with an upstream ISApl1.[7] Here PCR mapping and sequencing based on the initial genetic environment[1] showed that one isolate did not have a flanking ISApI1 (Table 1). This suggests that the dissemination of mcr-1 is likely facilitated by a diverse range of mobile genetic elements. We plan to commence full-genome sequencing in the near future to characterize the plasmids and mobile elements in detail. Because Singapore has limited farming and agricultural activity, mcr-1 is less likely to be acquired through contact with local livestock; although not yet conclusively proven, it appears that imported meat products and vegetables are more likely sources of mcr-1.[11, 12, 13]
  13 in total

1.  Dissemination of the mcr-1 colistin resistance gene.

Authors:  Maris S Arcilla; Jarne M van Hattem; Sebastien Matamoros; Damian C Melles; John Penders; Menno D de Jong; Constance Schultsz
Journal:  Lancet Infect Dis       Date:  2015-12-18       Impact factor: 25.071

2.  Colistin resistance gene mcr-1 in extended-spectrum β-lactamase-producing and carbapenemase-producing Gram-negative bacteria in Germany.

Authors:  Linda Falgenhauer; Said-Elias Waezsada; Yancheng Yao; Can Imirzalioglu; Annemarie Käsbohrer; Uwe Roesler; Geovana Brenner Michael; Stefan Schwarz; Guido Werner; Lothar Kreienbrock; Trinad Chakraborty
Journal:  Lancet Infect Dis       Date:  2016-01-08       Impact factor: 25.071

3.  Colistin-resistant Escherichia coli harbouring mcr-1 isolated from food animals in Hanoi, Vietnam.

Authors:  Surbhi Malhotra-Kumar; Basil Britto Xavier; Anupam J Das; Christine Lammens; Ha Thi Thu Hoang; Ngoc Thi Pham; Herman Goossens
Journal:  Lancet Infect Dis       Date:  2016-01-08       Impact factor: 25.071

4.  Occurrence of the Plasmid-Borne mcr-1 Colistin Resistance Gene in Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in River Water and Imported Vegetable Samples in Switzerland.

Authors:  Katrin Zurfuh; Laurent Poirel; Patrice Nordmann; Magdalena Nüesch-Inderbinen; Herbert Hächler; Roger Stephan
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

5.  Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1.

Authors:  Xu Yao; Yohei Doi; Li Zeng; Luchao Lv; Jian-Hua Liu
Journal:  Lancet Infect Dis       Date:  2016-02-01       Impact factor: 25.071

6.  Plasmid replicon typing.

Authors:  Timothy J Johnson; Lisa K Nolan
Journal:  Methods Mol Biol       Date:  2009

7.  Early emergence of mcr-1 in Escherichia coli from food-producing animals.

Authors:  Zhangqi Shen; Yang Wang; Yingbo Shen; Jianzhong Shen; Congming Wu
Journal:  Lancet Infect Dis       Date:  2016-03       Impact factor: 25.071

8.  Molecular characterization of NDM-1 producing Enterobacteriaceae isolates in Singapore hospitals.

Authors:  Jeanette Teo; Grace Ngan; Michelle Balm; Roland Jureen; Prabha Krishnan; Raymond Lin
Journal:  Western Pac Surveill Response J       Date:  2012-03-29

9.  Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015.

Authors:  Henrik Hasman; Anette M Hammerum; Frank Hansen; Rene S Hendriksen; Bente Olesen; Yvonne Agersø; Ea Zankari; Pimlapas Leekitcharoenphon; Marc Stegger; Rolf S Kaas; Lina M Cavaco; Dennis S Hansen; Frank M Aarestrup; Robert L Skov
Journal:  Euro Surveill       Date:  2015

10.  Colistin resistance gene mcr-1 and pHNSHP45 plasmid in human isolates of Escherichia coli and Klebsiella pneumoniae.

Authors:  Nicole Stoesser; Amy J Mathers; Catrin E Moore; Nicholas P J Day; Derrick W Crook
Journal:  Lancet Infect Dis       Date:  2016-01-08       Impact factor: 25.071

View more
  13 in total

1.  Emergence of the Plasmid-Mediated mcr-1 Gene in Clinical KPC-2-Producing Klebsiella pneumoniae Sequence Type 392 in Brazil.

Authors:  Caio Augusto Martins Aires; Orlando Carlos da Conceição-Neto; Thamirys Rachel Tavares E Oliveira; Carolina Frizzera Dias; Lara Feital Montezzi; Renata Cristina Picão; Rodolpho Mattos Albano; Marise Dutra Asensi; Ana Paula D'Alincourt Carvalho-Assef
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

Review 2.  The rise and spread of mcr plasmid-mediated polymyxin resistance.

Authors:  Sue C Nang; Jian Li; Tony Velkov
Journal:  Crit Rev Microbiol       Date:  2019-05-23       Impact factor: 7.624

3.  mcr-3 and mcr-4 Variants in Carbapenemase-Producing Clinical Enterobacteriaceae Do Not Confer Phenotypic Polymyxin Resistance.

Authors:  Jeanette W P Teo; Marimuthu Kalisvar; Indumathi Venkatachalam; Oon Tek Ng; Raymond T P Lin; Sophie Octavia
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

4.  Conjugative IncX1 Plasmid Harboring Colistin Resistance Gene mcr-5.1 in Escherichia coli Isolated from Chicken Rice Retailed in Singapore.

Authors:  Siyao Guo; Moon Y F Tay; Aung Kyaw Thu; Kelyn Lee Ghee Seow; Yang Zhong; Lee Ching Ng; Joergen Schlundt
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

Review 5.  An Update of Mobile Colistin Resistance in Non-Fermentative Gram-Negative Bacilli.

Authors:  Piyatip Khuntayaporn; Krit Thirapanmethee; Mullika Traidej Chomnawang
Journal:  Front Cell Infect Microbiol       Date:  2022-06-17       Impact factor: 6.073

Review 6.  Mobile Colistin Resistance (mcr) Genes in Cats and Dogs and Their Zoonotic Transmission Risks.

Authors:  Afaf Hamame; Bernard Davoust; Zineb Cherak; Jean-Marc Rolain; Seydina M Diene
Journal:  Pathogens       Date:  2022-06-17

7.  Expression characteristics of the plasmid-borne mcr-1 colistin resistance gene.

Authors:  Haifang Zhang; Minhui Miao; Jieting Yan; Min Wang; Yi-Wei Tang; Barry N Kreiswirth; Xia Zhang; Liang Chen; Hong Du
Journal:  Oncotarget       Date:  2017-11-20

Review 8.  Klebsiella pneumoniae in Singapore: Hypervirulent Infections and the Carbapenemase Threat.

Authors:  Ka Lip Chew; Raymond T P Lin; Jeanette W P Teo
Journal:  Front Cell Infect Microbiol       Date:  2017-12-12       Impact factor: 5.293

Review 9.  Illustrative examples of probable transfer of resistance determinants from food animals to humans: Streptothricins, glycopeptides, and colistin.

Authors:  Hattie E Webb; Frederick J Angulo; Sophie A Granier; H Morgan Scott; Guy H Loneragan
Journal:  F1000Res       Date:  2017-10-05

Review 10.  Occurrence and Characteristics of Mobile Colistin Resistance (mcr) Gene-Containing Isolates from the Environment: A Review.

Authors:  Madubuike Umunna Anyanwu; Ishmael Festus Jaja; Obichukwu Chisom Nwobi
Journal:  Int J Environ Res Public Health       Date:  2020-02-06       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.